IV 

118TH CONGRESS 

1ST SESSION H. RES. 709 

Supporting the designation of September 2023 as ‘‘National Cholesterol 

Education Month’’, and September 30, 2023, as LDL–C Awareness Day. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 20, 2023 

Mrs. CHERFILUS-MCCORMICK (for herself, Mrs. CAMMACK, Ms. ADAMS, Mr. 

CLEAVER, Mr. GARCI ́A of Illinois, Ms. SCHAKOWSKY, Mr. PAYNE, Mr. 

GREEN of Texas, Ms. KUSTER, Ms. BLUNT ROCHESTER, Mr. VEASEY, 

and Mr. JOHNSON of Georgia) submitted the following resolution; which 

was referred to the Committee on Energy and Commerce 

RESOLUTION 

Supporting the designation of September 2023 as ‘‘National 

Cholesterol Education Month’’, and September 30, 2023, 

as LDL–C Awareness Day. 

Whereas cardiovascular disease is the leading cause of death 

for men and women, including people of color in the 

United States, who have higher rates of cardiovascular 

disease and tend to develop this condition at an earlier 

age than non-Hispanic White populations; 

Whereas cardiovascular disease disproportionately affects underserved populations as 52.3 percent of Hispanic men 

and 42.7 percent of Hispanic women over the age of 20 

have cardiovascular disease, and 60.1 percent of Black 


lotter on DSK11XQN23PROD with BILLS
2 

•HRES 709 IH 

men and 58.8 percent of Black women 20 years of age 

and older have cardiovascular disease; 

Whereas projected rates of cardiovascular disease are expected to increase significantly in the United States by 

2060, disproportionately affecting communities of color; 

Whereas women’s awareness of cardiovascular disease as the 

leading cause of death has declined by approximately 20 

percent in the last decade, most significantly among 

younger women; 

Whereas rural places in the United States have higher death 

rates for cardiovascular disease and stroke, as well as a 

40-percent higher prevalence of cardiovascular disease 

than its urban counterparts; 

Whereas rural women experience higher maternal mortality 

rates compared to urban women, driven largely by increased cardiovascular deaths; 

Whereas risk factors contributing to cardiovascular disease 

and poor health outcomes include elevated low density 

lipoprotein ‘‘bad’’ cholesterol (LDL–C), high levels of 

lipoprotein(a) cholesterol, hypertension, obesity, low 

awareness of personal risk factors, genetics, geographic 

location, and inequitable access to care; 

Whereas lipoprotein(a) cholesterol is predominantly genetically inherited and can build up in the walls of blood vessels creating cholesterol deposits, or plaques, and lead to 

atherosclerotic cardiovascular disease; 

Whereas LDL–C is a modifiable risk factor for cardiovascular disease and lower LDL–C is associated with a 

reduced risk of heart attack and stroke; 

Whereas more than 25.5 percent of adults in the United 

States have high LDL–C; 


lotter on DSK11XQN23PROD with BILLS
3 

•HRES 709 IH 

Whereas more than 200 studies with over 2,000,000 patients 

have broadly established that elevated LDL–C unequivocally causes atherosclerotic cardiovascular disease; 

Whereas atherosclerotic cardiovascular disease, which is responsible for nearly 85 percent of cardiovascular deaths, 

is the build-up of cholesterol plaque within the walls of 

arteries and includes acute coronary syndrome, peripheral 

arterial disease, and events such as heart attacks and 

strokes; 

Whereas the resources needed to bend the curve in cardiovascular disease exist, yet 71 percent of 

hypercholesterolemia patients at high risk of a cardiovascular event never achieve recommended LDL–C treatment guideline thresholds; 

Whereas only 33 percent of people with atherosclerotic cardiovascular disease who are taking statins, a guideline 

recommended lipid lowering therapy, actually achieve 

LDL–C goals; 

Whereas only 27 percent of patients hospitalized for heart attack receive an LDL–C test in the 90 days following discharge from a hospital, as recommended by clinical 

guidelines; 

Whereas African-American adults were less likely than their 

White peers to receive an LDL–C test in the 90 days following discharge from a hospital, despite having a higher 

prevalence of cardiovascular disease; 

Whereas significant gaps in care lead to subsequent cardiovascular events; 

Whereas the Centers for Disease Control and Prevention’s 

Million Hearts program seeks to improve access to and 


lotter on DSK11XQN23PROD with BILLS
4 

•HRES 709 IH 

quality of care to reduce heart disease, stroke, and death; 

and 

Whereas September is recognized as National Cholesterol 

Education Month to raise awareness of cardiovascular 

disease and the importance of knowing one’s LDL–C 

number: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) encourages all people in the United States 

3 to know their LDL–C number; and 

4 (2) recognizes the urgent need for screening 

5 and treating of LDL–C to reduce the risk of cardio6 vascular disease and cardiovascular events such as 

7 heart attacks or strokes. 

Æ 


lotter on DSK11XQN23PROD with BILLS